MTEM stock forecast
Our latest prediction for Molecular Templates, Inc.'s stock price was made on the Sept. 21, 2018 when the stock price was at 5.52$.
In the short term (2weeks), MTEM's stock price should outperform the market by 4.62%. During that period the price should oscillate between -10.33% and +20.08%.
In the medium term (3months), MTEM's stock price should outperform the market by 1.94%. During that period the price should oscillate between -20.52% and +40.76%.Get email alerts
Create a solid portfolio with MTEM
About Molecular Templates, Inc.
Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded by Eric E. Poma, Jean Gariépy and Leigh Revers on October 17, 2001 and is headquartered in Austin, TX.
At the moment the company generates 21M USD in revenues.
On its last earning announcement, the company reported a loss of -2.61$ per share.
The book value per share is 2.29$
Three months stock forecastSept. 21, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|